Related references
Note: Only part of the references are listed.A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain
Sallwa M. Alshehre et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2020)
Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial
Jacques Donnez et al.
FERTILITY AND STERILITY (2020)
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments
Fabio Barra et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Adhesion proteins: Suitable therapeutic targets or biomarkers of therapy response for endometriosis?
Fabio Barra et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2019)
Clinical diagnosis of endometriosis: a call to action
Sanjay K. Agarwal et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2019)
Hormonal contraception in women with endometriosis: a systematic review
Giovanni Grandi et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2019)
Relugolix for the treatment of uterine fibroids
F. Barra et al.
DRUGS OF TODAY (2019)
Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain
F. Barra et al.
DRUGS OF TODAY (2019)
Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109
Oliver Pohl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Current and Emerging Therapeutics for the Management of Endometriosis
Simone Ferrero et al.
DRUGS (2018)
Current understanding on pharmacokinetics, clinical efficacy and safety o progestins for treating pain associated to endometriosis
Fabio Barra et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Investigational drugs for the treatment of endometriosis, an update on recent developments
Fabio Barra et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Current and emerging treatment options for endometriosis
Simone Ferrero et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence
Jeffrey T. Jensen et al.
FERTILITY AND STERILITY (2018)
Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent Endometriosis
Jenny Sadler Gallagher et al.
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2018)
Treg and NK cells related cytokines are associated with deep rectosigmoid endometriosis and clinical symptoms related to the disease
Barbara Yasmin Gueuvoghlanian-Silva et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2018)
Progesterone Resistance in Endometriosis: an Acquired Property?
Brett McKinnon et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Return of fertility after discontinuation of contraception: a systematic review and meta-analysis
Tadele Girum et al.
CONTRACEPTION AND REPRODUCTIVE MEDICINE (2018)
Oral and depot progestin therapy for endometriosis: towards a personalized medicine
Laura Buggio et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial
Tasuku Harada et al.
FERTILITY AND STERILITY (2017)
Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills
Robert F. Casper
FERTILITY AND STERILITY (2017)
The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial
Jenny Sadler Gallagher et al.
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2017)
Safety of medical treatments for endometriosis
Nicola Berlanda et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis
Giovanni Grandi et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2016)
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis A Randomized Controlled Trial
Amy D. DiVasta et al.
OBSTETRICS AND GYNECOLOGY (2015)
Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program
Thomas Strowitzki et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2015)
Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis
Debin Wu et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura
Matteo Morotti et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2014)
Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment
Matteo Morotti et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2014)
Triptorelin for the treatment of endometriosis
Umberto Leone Roberti Maggiore et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
SSRIs for Hot Flashes: A Systematic Review and Meta-Analysis of Randomized Trials
Taghreed Shams et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2014)
The impact of menopausal symptoms on work ability
Marije Geukes et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2012)
The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis
Kristof Chwalisz et al.
REPRODUCTIVE SCIENCES (2012)
Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain
David S. Guzick et al.
FERTILITY AND STERILITY (2011)
Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue
Yesim Bayoglu Tekin et al.
FERTILITY AND STERILITY (2011)
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review
Simone Ferrero et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
Ojvind Lidegaard et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue
Rodrigo Alves Ferreira et al.
CONTRACEPTION (2010)
High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners
Krithiga Ilangavan et al.
FERTILITY AND STERILITY (2010)
Efficacy of Gonadotropin-Releasing Hormone Agonist and an Extended-Interval Dosing Regimen in the Treatment of Patients with Adenomyosis and Endometriosis
Jia-li Kang et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2010)
Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial
T. Strowitzki et al.
HUMAN REPRODUCTION (2010)
Pregnancy outcome following in utero exposure to bisphosphonates
Shirley Levy et al.
BONE (2009)
Endometriosis Current Therapies and New Pharmacological Developments
Paolo Vercellini et al.
DRUGS (2009)
Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis-a randomized, double-blind, multicenter, controlled trial
Tasuku Harada et al.
FERTILITY AND STERILITY (2009)
Recurrence of endometriosis and its control
Sun-Wei Guo
HUMAN REPRODUCTION UPDATE (2009)
Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
Kurt A. Kennel et al.
MAYO CLINIC PROCEEDINGS (2009)
Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial
Tastuku Harada et al.
FERTILITY AND STERILITY (2008)
Formation of ethinyl estradiol in women during treatment with norethindrone acetate
Micheline C. Chu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
A retrospective case-control study of the use of hormone-related supplements and association with breast cancer
Timothy R. Rebbeck et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
GnRH analogs: Options for endometriosis-associated pain treatment
Frances R. Batzer
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2006)
Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain
WD Schlaff et al.
FERTILITY AND STERILITY (2006)
Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain
PG Crosignani et al.
HUMAN REPRODUCTION (2006)
Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate
P Vercellini et al.
FERTILITY AND STERILITY (2005)
Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis
CA Petta et al.
HUMAN REPRODUCTION (2005)
Safety and adverse effects associated with raloxifene: Multiple outcomes of raloxifene evaluation
D Grady et al.
OBSTETRICS AND GYNECOLOGY (2004)
The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial
S Soysal et al.
HUMAN REPRODUCTION (2004)
Prediction of the change in bone mineral density induced by gonadotropin-releasing hormone agonist treatment for endometriosis
H Matsuo
FERTILITY AND STERILITY (2004)
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: Effects on bone metabolism
S Palomba et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Estrogen 'add-back' and lipid profile during GnRH agonist (triptorelin) therapy
WR Al-Omari et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2001)
Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up
SJ Pierce et al.
FERTILITY AND STERILITY (2000)
Gonadotropin-releasing hormone agonist plus add-back hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial
HR Franke et al.
FERTILITY AND STERILITY (2000)
Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial
JD Miller
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (draw-back therapy)
M Tahara et al.
FERTILITY AND STERILITY (2000)
Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial
F Parazzini et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2000)
Share Paper
